Neurology Medical News about muscular dystrophy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Asymptomatic elevation of serum creatine kinase leading to the diagnosis of 4q35 facioscapulohumeral muscular dystrophy
Journal of Clinical Neuroscience, 07/30/09

Zouvelou V et al. – The clinical spectrum of facioscapulohumeral muscular dystrophy (FSHD) ranges from asymptomatic individuals with minimal clinical signs to patients who are wheelchair–bound. The authors describe a patient with persistent, asymptomatic hyperCKemia who received the diagnosis of 4q35 FSHD after a thorough stepwise investigation.

<< Previous
Brown tumour of the spine in a renal transplant patient

Next >>
Recurrent malignant peripheral nerve sheath tumour in a patient...

Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy
Paediatric Anaesthesia, 11/23/09 Relevance Score: 67%%

Exon Skipping Therapy Shows Promise in Prevention or Delay of Heart Disease Associated with Duchenne Muscular Dystrophy
AVI BioPharma, 10/20/09 Relevance Score: 66%%

Facioscapulohumeral muscular dystrophy: Do neurotrophins play a role
Muscle & Nerve, 10/20/09 Relevance Score: 66%%

GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
GlaxoSmithKline, 10/14/09 Relevance Score: 66%%

Diagnosis and new treatments in muscular dystrophies
Postgraduate Medical Journal, 11/10/09 Relevance Score: 65%%